📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for KINS.
💹 Market Data
Market Cap$222.34M
Shares Outstanding14.48M
Float11.57M
Cash$11.36M
Debt$4.25M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 3.1% shares (2025Q4 vs prior)
102 institutional holders · 8.17M shares
#1
BlackRock, Inc.
772.3K shares
#2
VANGUARD GROUP INC
638.6K shares
#3
ROYCE & ASSOCIATES LP
448.7K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest366.4K
Days to Cover2.6
% of Float3.2%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
4
INSIDER TRANSACTION
Apr 20, 2026
4
INSIDER TRANSACTION
Apr 17, 2026
3
FORM3
Mar 16, 2026
4
INSIDER TRANSACTION
Mar 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for KINS
📊 KINS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 KINS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.